341-24-2 Usage
General Description
7-Fluoro indazole is a chemical compound with the molecular formula C7H6FN3. It is a fluorinated derivative of indazole, a five-membered aromatic ring with two nitrogen atoms. 7-Fluoro indazole is a building block in the synthesis of pharmaceuticals and agrochemicals, and it is also used as a research tool in medicinal chemistry and drug discovery. It exhibits potential biological activity and has been studied for its potential applications in the treatment of various diseases and conditions. Additionally, 7-Fluoro indazole has been investigated for its potential as a ligand in coordination chemistry and as a component in the design of new materials.
Check Digit Verification of cas no
The CAS Registry Mumber 341-24-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,4 and 1 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 341-24:
(5*3)+(4*4)+(3*1)+(2*2)+(1*4)=42
42 % 10 = 2
So 341-24-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H5FN2/c8-6-3-1-2-5-4-9-10-7(5)6/h1-4H,(H,9,10)
341-24-2Relevant articles and documents
Synthesis, antifungal activity and qsar of novel pyrazole amides as succinate dehydrogenase inhibitors
Du, Shijie,Li, Zhonghao,Tian, Zaimin,Xu, Lu
, p. 74 - 85 (2018/01/26)
We design and synthesize a series of novel pyrazole amides based on the commercialized fungicides and our previous work. The antifungal activity was tested in vitro by mycelial growth inhibition assay. The results show that all the compounds are of antifungal activities against the tested fungi at different levels. Among them, N-(2-(7-bromo-5-chloro-1H-indazol-1-yl)phenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide (Vk) exhibited higher antifungal activity than boscalid against two fungi. Molecular docking study revealed that the carbonyl oxygen atom of Vk forms two hydrogen bonds toward the hydroxyl hydrogens of TYR58 and TRP173.
HETEROCYCLE DERIVATIVE HAVING PGD2 RECEPTOR ANTAGONIST ACTIVITY
-
Paragraph 0626, (2014/07/22)
The present invention is related to a compound represented by formula (I), wherein X1, X2, X3, X4, X5, R5, R6, R7, R8, n, p, q, ring A and ring B are as described in the specification, or a